Navigation Links
Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly's Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
Date:9/26/2013

BARCELONA, Spain, Sept. 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive patient-reported health outcomes from a Phase III clinical trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes. These results will be presented at the 49th European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Spain. 

In addition to reductions in HbA1c (hemoglobin A1c) levels and weight at 26 and 52 weeks with dulaglutide 1.5 mg,1 dulaglutide-treated patients reported significant, positive improvements compared to baseline across several patient-reported indicators of diabetes management, measured using validated questionnaires, including:

  • satisfaction with treatment and rates of perceived hyperglycaemia as measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ);
  • weight-related self-perception (Impact of Weight on Self-Perception (IW-SP) and Ability to Perform Physical Activities of Daily Living Questionnaires (APPADL)); and
  • perceived current health status (EuroQoL 5-Dimension Questionnaire (EQ-5D)).2

"Patients' perception of how diabetes treatment may affect their lives is an important consideration when choosing a medication. We are pleased that in this study, patients treated with dulaglutide reported improvements in several patient-reported outcome measures," said Gwen Krivi, Ph.D., vice president, Lilly Diabetes product development. "These results, coupled with dulaglutide's positive clinical data, suggest that, if approved, our investigational once-weekly GLP-1 may be an attractive treatment option f
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
4. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
5. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
6. eCardios CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.
7. CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting
8. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
9. Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
10. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
11. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... -- Royal Philips (NYSE: PHG AEX: PHIA) ... 56th Annual Meeting in San Francisco ... consistency and accuracy in cancer treatment. Producing quality results ... oncology solutions underscore Philips, dedication to leading healthcare into ... "Philips is leveraging our expertise in CT, ...
(Date:9/12/2014)... MARIETTA, Ga. , Sept. 12, 2014  WellStar ... Georgia and became the second in the ... sleep apnea.  As part of WellStar Health System, Paulding ... continually offering the latest treatments and solutions. ... sleep apnea in patients who are unable to use ...
(Date:9/12/2014)... According to the new research ... Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by ... & Prescription Based - Global Forecast to 2018" published ... over the forecast period of 2013 to 2018. The ... 9.3% from 2013 to 2018, to reach $27.5 billion ...
Breaking Medicine Technology:Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3WellStar Pioneers New Sleep Apnea Treatment 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... May 16, 2011 /PRNewswire-Asia/ -- Global Pharm Holdings ... "Company"), a China-based leading vertically integrated pharmaceutical company ... cultivation businesses through its subsidiaries in the Anhui, ... financial results for the first quarter ended March ...
... MAYWOOD, N.J., May 16, 2011 New Jersey Center ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 2Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 3Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 4Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 5Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 6Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 7Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 8Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 9Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 10Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 11New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2
(Date:9/14/2014)... 14, 2014 UWDress.com, is an internationally ... has recently announced its new range of cocktail ... bring more benefits to worldwide ladies, the company is ... lace wedding outfits, blue evening gowns, black formal gowns ... 70 percent off. , The company’s senior spokesman ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 East ... a renowned Vancouver chiropractic clinic, has recently published ... In this latest blog on the topic, Dr ... clarified several myths that people have regarding this ... between the services of a chiropractor and that ...
(Date:9/13/2014)... -- Researchers say they,ve tracked specific activity in the ... clear whether imagination and memory were distinct processes, so ... decided to explore the issue. "I was thinking ... imagining myself in the future, and I started wondering ... Ashby said in a university news release. "I ...
(Date:9/13/2014)... Top10BestSEOHosting.com is a well-known review website the ... web hosting suppliers and announced that FatCow ( ... ASP.NET hosting suppliers in 2014. According to the ... very popular way for webmasters to build dynamic ... is happy to introduce Arvixe, FatCow.com, and Hostgator ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 New York is ... declaring September 23, 2014, Falls Prevention Awareness Day. , ... injuries for those 65 years of age and over. Every ... department for a fall-related injury. Every day because of a ... New Yorkers are hospitalized; and two New Yorkers die. The ...
Breaking Medicine News(10 mins):Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 3Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 4
... BEDFORD, Mass., Sept. 2 Hologic, Inc. (Nasdaq: HOLX ... at the 2009 Morgan Stanley Global Healthcare Unplugged Conference in New ... , , Interested parties are invited to ... the investor section of the company,s website at www.hologic.com/investor ...
... not create ,safety concern, agency says , WEDNESDAY, Sept. 2 ... many lipsticks are higher than those reported in 2007 by ... new analysis, conducted by the U.S. Food and Drug Administration ... of Cosmetic Science , used new techniques to determine the ...
... , , , ... the American Veterinary Medical Association (AVMA), was named chief executive officer ... to highlight the connections between human, animal, and environmental health. , ... group,s first board of directors meeting on August 14 in Washington, ...
... PHILADELPHIA (September 2, 2009) The Fox Chase Cancer ... National Center for Research Resources of the National Institutes ... facility. The new facility will support advanced ... the way for the development of new treatments. The ...
... space, may be the stuff dreams are made of. ... in those clouds, and it,s not dreams butmothballs? ... Georgia have just shown for the first time that ... as the Unidentified Infrared Bands (UIRs) is a gaseous ...
... Post study, approximately 20% of U.S. soldiers returning from ... a substantial number with post-traumatic stress disorder (PTSD), and ... become unacceptable to Army commanders and the soldiers, families. ... however, doctors will now be able to forecast a ...
Cached Medicine News:Health News:Lead Levels in Many Lipsticks Higher Than Reported 2Health News:Lead Levels in Many Lipsticks Higher Than Reported 3Health News:Former AVMA President to Head National Health Commission 2Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 3Health News:Keeping the suicidal soldier alive 2
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
... PxE Thermal Cycler (PxE) is a licensed 96 ... features for value for money thermal cycling. ... sixteen years experience in manufacturing and retains a ... synonymous with other products in the range. ...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
... With Exceptional Performance The sleek ... might be the first things ... is designed for performance. With ... premium, its small footprint is ...
Medicine Products: